WTA Implements New Rules for Women’s Tennis Eligibility

The Women’s Tennis Association (WTA) has introduced a new policy that requires genetic testing for individuals identifying as women to compete in women’s sports. This move aims to ensure fair competition.

According to the WTA’s recent policy, all participants must undergo genetic testing to check for the SRY gene, which is found on the Y chromosome of males. If a player tests negative for this gene, they will be cleared to compete in the women’s division. However, a positive result will lead to a more in-depth review of their eligibility.

Players who opt out of testing will have to sign a document acknowledging that their refusal will prompt an investigation and could lead to disciplinary measures.

“The WTA Women’s Eligibility Policy is designed to promote equal athletic opportunity in women’s professional tennis and maintain fair competition for all players participating in WTA tournaments,” the policy states.

The association also emphasized its commitment to treating all athletes with respect, acknowledging that the matter is sensitive and complex. They indicated that these changes were made after discussing the topic with existing members and looking at similar actions taken by other international women’s sporting organizations.

This rule replaces the former guideline, which allowed transgender competitors to participate as long as their testosterone levels had been under 2.5 nmol/L for at least two years prior to competition.

Tennis great Martina Navratilova praised the WTA’s action, describing it as “a step in the right direction.”

Furthermore, it’s notable that the International Olympic Committee has also revised its policy to include gender testing leading up to the 2028 Olympics in Los Angeles.